Back

Tricuspid Regurgitation: Insights from the TRILUMINATE Pivotal Roll-In Cohort

28 August 2022 (14:56 - 15:15)
Organised by:
Congress Presentation Part of: Latest science in valvular heart disease Tricuspid Valve Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Paul Sorajja

Minneapolis Heart Institute Foundation, Minneapolis (United States of America)

3 More presentations in this session

Presentation thumbnail
ENVISAGE-TAVI AF predictors of all cause Mortality.
Professor G. Dangas (New York, US)
Slides Video
Presentation thumbnail
COAPT PAS: 1 Year Outcomes from 5000 Patients.
Assistant Professor K. Goel (Nashville, US)
Slides Video
Presentation thumbnail
Relative survival after mitral TEER in MitraSwiss Patients.
Doctor L. Biasco (Cirie, IT)
Slides Video

Access the full session

Session thumbnail
Latest science in valvular heart disease
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 14:56 CET
You may be interested in
thumbnail
Congress Presentation
The impact of baseline right heart size and function on heart failure hospitalization and mortality: 2-year results of the TRILUMINATE Trial
31 August 2025
thumbnail
Congress Presentation
Revolutionising tricuspid valve therapies: from forgotten to the forefront
30 August 2024
thumbnail
Congress Presentation
Hype, hope, and how to tell the difference in tricuspid regurgitation - discussion
11 December 2025
thumbnail
Congress Presentation
What is the evidence for TEER in tricuspid regurgitation?
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources